Noninferiority clinical trial comparing the bowel cleansing efficacy of sodium phosphate tablets (Quiklean®) with a polyethylene glycol/bisacodyl kit

doi:10.3748/wjg.v27.i5.428

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5611)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

352

WORD

187

HTML

2833

Figures (1-1)

312

Tables (1-5)

286

Sum=3970

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

492

Download

1149

Sum=1641

Feb 7, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Feb 7, 2021; 27(5): 428-441
Published online Feb 7, 2021. doi: 10.3748/wjg.v27.i5.428

Noninferiority clinical trial comparing the bowel cleansing efficacy of sodium phosphate tablets (Quiklean^®) with a polyethylene glycol/bisacodyl kit

Shih-Ya Hung, Hung-Chang Chen, Tao-Wei Ke, Jiann-Hwa Chen, Koung-Hung Hsiao, Hwei-Ming Wang, Hua-Che Chiang, Sheng-Chi Chang, Yi-Chang Chen, Ming-Hao Hsieh, Yuan-Yao Tsai, Yo-Wen Hsieh, William Tzu-Liang Chen

Shih-Ya Hung, Graduate Institute of Acupuncture Science, China Medical University, Taichung 40402, Taiwan

Shih-Ya Hung, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan

Hung-Chang Chen, Tao-Wei Ke, Hwei-Ming Wang, Hua-Che Chiang, Sheng-Chi Chang, Yi-Chang Chen, Ming-Hao Hsieh, Yuan-Yao Tsai, Division of Colorectal Surgery, Department of Surgery, China Medical University Hospital, Taichung 40447, Taiwan

Jiann-Hwa Chen, Division of Gastroenterology, Taipei Tzu Chi Hospital, Taipei 23142, Taiwan

Koung-Hung Hsiao, Division of Colorectal Surgery, Taipei Tzu Chi Hospital, Taipei 23142, Taiwan

Yo-Wen Hsieh, Department of Pharmacy, China Medical University Hospital, Taichung 40447, Taiwan

William Tzu-Liang Chen, Department of Colorectal Surgery, China Medical University Hsinchu Hospital, Zhubei 30272, Taiwan

William Tzu-Liang Chen, School of Medicine, China Medical University, Taichung 40402, Taiwan

Author contributions: Chen WTL and Chen HC worked on conceptualization, methodology, and project administration; Chen WTL and Hung SY worked on original draft preparation and manuscript editing; Chen HC, Ke TW, Chen JH, Hsiao KH, Wang HM, Chiang HC, Chang SC, Chen YC, Hsieh MH, Tsai YY, and Chen WTL performed colonoscopy, data collection, and data curation; Hsieh YW worked on drug dispensing and pharmaceutical care.

Supported by The China Medical University Hospital, No. DMR-108-125.

Institutional review board statement: This study was reviewed and approved by the Institutional Review Boards of China Medical University Hospital (CMUH107-REC2-151) and Taipei Tzu Chi Hospital (08-FS-030). Study methods were conducted in accordance with the Institutional Review Board committee guidelines.

Clinical trial registration statement: This study has been registered at https://clinicaltrials.gov/ct2/show/NCT03992365 (ID: NCT03992365).

Informed consent statement: Written informed consent was provided by all study participants.

Conflict-of-interest statement: Quiklean^® was provided by Universal Integrated Corporation (Taiwan). The authors have no conflicts of interest to declare.

Data sharing statement: No additional data are available.

CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Corresponding author: William Tzu-Liang Chen, MD, Superintendent, Department of Colorectal Surgery, China Medical University Hsinchu Hospital, No. 199 Sec. 1, Xinglong Road, Zhubei 30272, Taiwan. wtchen@mail.cmuh.org.tw

Received: November 5, 2020
Peer-review started: November 5, 2020
First decision: December 13, 2020
Revised: December 24, 2020
Accepted: January 6, 2021
Article in press: January 6, 2021
Published online: February 7, 2021

Core Tip

Core Tip: The bowel cleanser 32-tablet sodium phosphate (Quiklean^®) is an adequate bowel cleansing preparation with better tolerability and acceptability than the standard comparator 2-L polyethylene glycol/bisacodyl (Klean-Prep/Dulcolax^®).